SEC Form 4 · accession 0001127602-16-058896
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Eberly
Officer — EVP; Pres, Chief Comm Officer
Period of report
Jul 27, 2016
Accepted (ET)
Jul 29, 2016 · 2:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 46,219 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $20.48 | Jul 27, 2016 | A | 20,000 | A | — | Jul 27, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1These options are awarded under the 2012 Stock Incentive Plan in connection with promotion to President, Chief Commercial Officer, and vest in four equal installments from the date of grant (i.e., 25% per year until fully vested on July 27, 2020).